BAILARD, INC. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 94 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$829,000
+1558.0%
22,000
+69.2%
0.03%
+933.3%
Q3 2019$50,000
-35.9%
13,0000.0%0.00%
-40.0%
Q2 2019$78,000
-44.7%
13,000
+23.8%
0.01%
-44.4%
Q1 2019$141,00010,5000.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders